Santhera Pharmaceuticals Logo

Santhera Pharmaceuticals

🇨🇭
SANN
CH1276028821

Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company based in Pratteln. It develops and markets treatments for rare neuromuscular diseases, including Duchenne muscular dystrophy. Its shares are listed on the SIX Swiss Exchange.

Next Quarterly Earnings

Monday, September 21, 2026
CW 39
Pre-Market
In 25 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until September 21, 2026

Stock Price

Frequently asked questions

When will Santhera Pharmaceuticals report its next quarterly earnings?

Santhera Pharmaceuticals is scheduled to report its next quarterly earnings on 09/21/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Santhera Pharmaceuticals last report quarterly earnings?

Santhera Pharmaceuticals last reported quarterly earnings on 4/28/2026 (Q1 2026). Earnings per share (EPS) came in at -0.79 CHF.

How do I add the Santhera Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:-CHF 0.09
Actual:
Q1 2026
Estimate:
Actual:-CHF 0.79
Price reaction (1 day):+1.0 %
Price reaction (7 days):-9.0 %

Company Information

Name
Santhera Pharmaceuticals
Ticker Symbol
SANN
ISIN
CH1276028821
Country
🇨🇭
Switzerland
Sector